Our main findings are that patients with later onset of depression exhibit higher levels of two inflammatory markers (i.e., CRP, NLR) and lower levels of cytotoxic T cells after adjusting for sociodemographics, lifestyle factors, and antidepressant medication. The gene discussed is CRP; the disease is depressive disorder.